Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Assessment of Response to Dual Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma Using 18F-FLT PET/CT and PET/MR

NCT02891616 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02891616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02891616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Assessment of Response to Dual Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma Using 18F-FLT PET/CT and PET/MR
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Terminated
Start date
October 10, 2016
Completion date
December 31, 2017
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma